Browsing by Subject
Now showing items 1-4 of 4
-
SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry
(Lippincott Williams & Wilkins, 2021-06-24) -
Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19
(Nature Research, 2021-06-01)